Target intelligence / Profile preview

Cancer cell lines

Molecular classification
Other, Experimental model system
01

Overview

Cancer cell lines are immortalized populations of cells derived from human or animal tumors that are cultured in vitro for extended periods. They serve as the primary workhorses in oncology research, allowing scientists to study the fundamental biology of cancer, including growth mechanisms, genetic mutations, and response to therapeutic agents (National Cancer Institute, 2023). While they provide a high-throughput and relatively inexpensive platform for drug screening and molecular characterization, they are not pharmacological targets themselves; rather, they are the substrates that contain various molecular targets like receptors and enzymes. Significant limitations include the loss of the original tumor's heterogeneity and the absence of the physiological microenvironment, which can result in poor translation from laboratory results to clinical efficacy (Gillet et al., 2013, Nature Reviews Cancer). Consequently, while essential for early-stage drug discovery, cancer cell lines are considered experimental models rather than specific therapeutic molecules or receptors.

Other names
Tumor cell linesImmortalized cancer cell linesIn vitro cancer modelsMalignant cell lines
02

Mechanism of action

Not applicable as cancer cell lines are experimental model systems rather than individual therapeutic targets or molecules.

03

Biological functions

Cell proliferationApoptosisDrug resistance modelingMetastatic potential assessmentSignal transduction modeling
04

Disease associations

Cancer
05

Safety considerations

Genetic drift over passagesCross-contamination with other cell lines (e.g., HeLa)Lack of tumor microenvironment and stromal interactionsInability to fully replicate in vivo drug metabolism and toxicity
06

Biomarkers

Short Tandem Repeat (STR) profilingMutational status (e.g., TP53, KRAS)Microsatellite instability (MSI)Gene expression signatures

Beyond the preview

Go deeper on Cancer cell lines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer cell lines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call